Open access
Jul 2026
Unlocking Therapeutic Vulnerabilities in Leukemia with CRISPR-Based Screens 2255583
It is hypothesized that genome-wide CRISPRa screening will uncover subtype-specific genetic dependencies and drug resistance mechanisms, offering novel therapeutic insights in leukemia subtype biology, guiding future personalized treatment strategies.
Jeffrey Sullivan, Xiaozen Wen, Gabriela Flores-Vargas et al.
· Journal of Immunology · 0 citations